Key customers include hospitals, alternate site facilities such as nursing and outpatient surgical care facilities , wholesalers, and other drug manufacturers. The name is derived from the words hospital, spirit, inspire and the Latin word "spero," which means "hope.
What is it like to work at Hospira?
Something I thought I was clearly unqualified to do. I was able to do well in this assignment but was let go due to issues they were having with my manager who has since been let go. This facility is now Pfizer. Didn't appreciate being let go because of issues with my boss. What are people saying about the leadership at Hospira? If you were in charge, what would you do to make Hospira a better place to work? What advice would you give the CEO of Hospira about how to improve it?
What are people discussing at Hospira? Top questions about Hospira What is the work environment and culture like at Hospira? How did you feel about telling people you worked at Hospira?
It also runs 15 manufacturing facilities globally. The firm outsources some production to third-party suppliers. In addition to a direct sales force, Hospira operates marketing and distribution centers across the US. For existing customers, it offers a variety of online self-service tools. Hospira's internal research programs are largely focused on the areas of generic specialty injectable pharmaceuticals.
The company introduces a number of new generic injectables each year, and it is working to move existing products into new countries. In addition, Hospira is looking to develop new generic injectable biosimilars, non-generic specialty injectables, and medication management systems. In the company extended its partnership with Cerner to enhance the interoperability between its smart IV infusion devices and Cerner's CareAware technology. To reduce expenses, the company closed its Clayton, North Carolina, manufacturing facility in Two years later, it announced plans to slowly shutter its plant in the Dominican Republic; those operations are being moved to Costa Rica.
Also that year, Hospira was acquired by pharmaceutical giant Pfizer. By purchasing Hospira, Pfizer grew its Global Established Pharmaceutical segment, which specializes in sterile injectable products and biosimilars.
Almost immediately after the acquisition, Pfizer began selling off Hospira assets, partly to meet antitrust regulations and partly to divest some of Hospira's struggling operations. Other moves include the closures of Hospira's logistics centers in Atlanta, Dallas, Los Angeles, and King of Prussia, Pennsylvania, as well as a manufacturing center in Boulder, Colorado.
Hospira was formed through the spinoff of drug manufacturer Abbott Laboratories ' hospital supplies business in Free sample resumes and expert advice. Free sample cover letters and expert advice. In , Pfizer signed an agreement to acquire Hospira. Sodium thiopental is an anesthetic discovered by Abbott Laboratories in the s.
The WHO considers it an essential drug. However, it is also used as part of the lethal injection protocol in many US states. On January 21, , the company announced that it would stop producing sodium thiopental. Hospira had recently moved production of the drug from a plant in North Carolina to a plant in Liscate , Italy.
However, the Italian government threatened to bar its export unless Hospira monitored the entire supply chain all the way to the end user in order to ensure it only used for medical purposes and not converted for use in executions. The Italian constitution bans the use of capital punishment. Company officials determined there was no way it could prevent sodium thiopental from being used in executions, and did not want to expose their employees to liability.
In April , Hospira announced a legal settlement with Sanofi-Aventis. Under the settlement terms, Hospira agreed to stop selling oxaliplatin injection in the United States by June 30, , and can relaunch the product in the United States on Aug. In , the U. Congress passed legislation that would allow the marketing of biosimilar drugs in the United States. The legislation would allow 12 years of data exclusivity for brand-name biologics. Some consumer groups, like AARP, oppose this provision, saying it would cause lack of access to the promise of such drugs.
Its competitors in medication management systems include Baxter, B. In two security researchers independently identified what were described as severe defects in Hospira's PCA system firmware , the software controlling various of their drug infusion equipment CVE  and further advisory ICSAB .
Numerous remote exploit vulnerabilities were found, in what was believed to be the first FDA safety advisory of its kind.